1.29%
6.94%
10.39%
13.75%
47.47%
107.28%
301.02%
AI Spotlight on SOL
Company Description
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home medical assistance and related medical equipment in Italy and internationally.The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use.It also provides home oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.
In addition, it provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services.Further, it designs, constructs, and manages bio banks; distribution of medical and technical gases; produces and sells hydroelectric power; offers pre-and post-natal diagnostic screening services; produces and sells diagnostic systems; researches, develops, and markets products for research, diagnosis and clinical application in the hospital, environmental, veterinary and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples.Its products are used in the chemical, electronics, steel, metal, and food industries, as well as in environmental protection, and research and healthcare sectors.
The company was founded in 1927 and is headquartered in Monza, Italy.SOL S.p.A. is a subsidiary of Gas and Technologies World BV.
Market Data
| Last Price | 39.3 |
| Change Percentage | 1.29% |
| Open | 39.2 |
| Previous Close | 38.8 |
| Market Cap ( Millions) | 3565 |
| Volume | 22491 |
| Year High | 39.7 |
| Year Low | 25.6 |
| M A 50 | 36.98 |
| M A 200 | 35.07 |
Financial Ratios
| FCF Yield | 3.35% |
| Dividend Yield | 0.94% |
| ROE | 18.33% |
| Debt / Equity | 57.06% |
| Net Debt / EBIDTA | 73.83% |
| Price To Book | 3.68 |
| Price Earnings Ratio | 20.46 |
| Price To FCF | 29.85 |
| Price To sales | 1.86 |
| EV / EBITDA | 8.51 |
News
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Technical Gasses
Expected Growth : 7 %
What the company do ?
Technical Gases from SOL S.p.A. are high-purity gases used in various industrial applications, including manufacturing, welding, and laboratory analysis.
Why we expect these perspectives ?
SOL S.p.A.'s 7% growth in Technical Gases is driven by increasing demand from industrial manufacturing, particularly in the automotive and aerospace sectors. Additionally, growing adoption of clean energy technologies, such as hydrogen fuel cells, and rising use of medical gases in healthcare facilities also contribute to this growth.
Segment n°2 -> Home Care
Expected Growth : 9 %
What the company do ?
Home Care from SOL S.p.A. provides personalized medical and non-medical assistance to individuals in the comfort of their own homes.
Why we expect these perspectives ?
SOL S.p.A.'s Home Care segment growth of 9% is driven by increasing demand for eco-friendly and sustainable cleaning products, expansion into emerging markets, and strategic partnerships with key retailers. Additionally, the company's focus on product innovation, digital marketing, and competitive pricing strategies have contributed to its growth momentum.
Sol S.P.A. Products
| Product Range | What is it ? |
|---|---|
| Industrial Gases | SOL S.p.A. offers a wide range of industrial gases, including oxygen, nitrogen, argon, and carbon dioxide, used in various industries such as manufacturing, healthcare, and food processing. |
| Medical Gases | SOL S.p.A. provides medical gases, including oxygen, nitrous oxide, and medical air, used in hospitals, clinics, and medical facilities. |
| Specialty Gases | SOL S.p.A. offers specialty gases, including high-purity gases, calibration gases, and rare gases, used in industries such as electronics, pharmaceuticals, and research. |
| Cryogenic Gases | SOL S.p.A. provides cryogenic gases, including liquid nitrogen, liquid oxygen, and liquid argon, used in industries such as energy, aerospace, and healthcare. |
| Gas Mixtures | SOL S.p.A. offers custom gas mixtures, including calibration gases, laser gases, and specialty gas blends, used in industries such as manufacturing, healthcare, and research. |
| Equipment and Accessories | SOL S.p.A. provides equipment and accessories, including gas cylinders, regulators, and valves, used in industries such as manufacturing, healthcare, and research. |
SOL S.p.A.'s Porter Forces
Threat Of Substitutes
The threat of substitutes for SOL S.p.A. is medium due to the presence of alternative energy sources and the increasing adoption of renewable energy.
Bargaining Power Of Customers
The bargaining power of customers for SOL S.p.A. is low due to the company's strong brand reputation and the lack of switching options for customers.
Bargaining Power Of Suppliers
The bargaining power of suppliers for SOL S.p.A. is medium due to the presence of multiple suppliers and the company's dependence on a few key suppliers.
Threat Of New Entrants
The threat of new entrants for SOL S.p.A. is high due to the low barriers to entry and the increasing demand for renewable energy.
Intensity Of Rivalry
The intensity of rivalry for SOL S.p.A. is high due to the presence of several established players and the increasing competition in the renewable energy market.
Strength
Capital Structure
| Value | |
|---|---|
| Debt Weight | 37.91% |
| Debt Cost | 3.95% |
| Equity Weight | 62.09% |
| Equity Cost | 6.46% |
| WACC | 5.51% |
| Leverage | 61.05% |
SOL S.p.A. : Quality Control
SOL S.p.A. passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| BANB.SW | Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide … |
| DESN.SW | Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company's chemicals and … |
| KEMIRA.HE | Kemira Oyj operates as a chemicals company in Finland, rest of Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in two segments, Pulp & Paper … |
| SOLB.BR | Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic … |
| BZU.MI | Buzzi Unicem S.p.A., together with its subsidiaries, manufactures, distributes, and sells cement, ready-mix concrete, and aggregates. It also offers special binders, safety sheets, and clinkers, as well as construction hydraulic … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Buzzi Unicem
A-Score
1-Year Total Return ->
🥈
Solvay
A-Score
1-Year Total Return ->
🥉
Kemira
A-Score
1-Year Total Return ->
4
SOL
A-Score
1-Year Total Return ->
5
Dottikon Es Holding
A-Score
1-Year Total Return ->
6
